BioCentury
ARTICLE | Company News

Allergan, Allergan Specialty deal

April 23, 2001 7:00 AM UTC

Eye care and specialty pharma company AGN, which spun out ASTI in 1997, exercised its option to reacquire all of ASTI's 3.3 million shares for $21.70 per share, or $71 million in cash. The purchase is...